This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB02807/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB02807/identifier/pubchem-compound/
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n4http://linked.opendata.cz/resource/drugbank/drug/DB02807/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02807/identifier/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02807
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n8:DB02807 n9:DB02807
dcterms:title
D-2-Keto-3-Deoxygalactonate
adms:identifier
n4:46508069 n11:RSH n12:21596768 n13:DB02807
n5:IUPAC-Name
n6:271B5A38-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5A3E-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5A3D-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5A3A-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5A3B-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5A3C-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5A36-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5A34-363D-11E5-9242-09173F13E4C5 n6:271B5A37-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5A35-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5A44-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5A45-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5A3F-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5A40-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5A42-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5A41-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5A43-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5A4A-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5A4C-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5A4D-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5A49-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5A48-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5A4B-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5A39-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5A46-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5A47-363D-11E5-9242-09173F13E4C5